ProfileGDS4284 / 1566427_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 13% 33% 24% 8% 14% 14% 10% 39% 27% 28% 18% 18% 8% 35% 18% 11% 34% 32% 41% 14% 18% 49% 15% 33% 10% 16% 15% 38% 5% 11% 4% 10% 19% 10% 38% 41% 12% 19% 35% 18% 8% 26% 18% 40% 13% 24% 41% 15% 62% 12% 13% 5% 18% 35% 18% 8% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control20.218513
GSM687648Patient 402 control88.867233
GSM687653Patient 403 control51.017124
GSM687658Patient 404 control14.33518
GSM687663Patient 411 control26.848314
GSM687668Patient 422 control23.313914
GSM687673Patient 424 control18.29910
GSM687678Patient 425 control132.45839
GSM687683Patient 427 control71.77727
GSM687688Patient 428 control69.716528
GSM687695Patient 441 control59.189318
GSM687699Patient 443 control39.928718
GSM687704Patient 444 control13.78238
GSM687707Patient 448 control131.0435
GSM687712Patient 449 control33.855418
GSM687719Patient 450 control24.607611
GSM687724Patient 451 control116.53534
GSM687728Patient 452 control101.9732
GSM687646Patient 401 treated 24h140.29541
GSM687649Patient 402 treated 24h19.532914
GSM687665Patient 411 treated 24h38.60518
GSM687651Patient 402 treated 4 weeks224.95849
GSM687667Patient 411 treated 4 weeks28.20515
GSM687670Patient 422 treated 24h99.852633
GSM687671Patient 422 treated 4 weeks16.272410
GSM687654Patient 403 treated 24h25.640716
GSM687675Patient 424 treated 24h30.433415
GSM687685Patient 427 treated 24h123.92938
GSM687656Patient 403 treated 4 weeks8.234855
GSM687677Patient 424 treated 4 weeks18.490311
GSM687687Patient 427 treated 4 weeks6.843474
GSM687692Patient 428 treated 4h16.654110
GSM687716Patient 449 treated 4h37.591819
GSM687722Patient 450 treated 4h22.79510
GSM687680Patient 425 treated 24h122.50938
GSM687690Patient 428 treated 24h130.10641
GSM687700Patient 443 treated 24h34.355612
GSM687705Patient 444 treated 24h34.572219
GSM687714Patient 449 treated 24h97.319135
GSM687721Patient 450 treated 24h42.951518
GSM687682Patient 425 treated 4 weeks12.49128
GSM687694Patient 428 treated 4 weeks57.230426
GSM687702Patient 443 treated 4 weeks38.901418
GSM687718Patient 449 treated 4 weeks132.27540
GSM687723Patient 450 treated 4 weeks23.659913
GSM687661Patient 404 treated 4h56.766924
GSM687710Patient 448 treated 4h142.39641
GSM687726Patient 451 treated 4h30.680115
GSM687730Patient 452 treated 4h613.07762
GSM687660Patient 404 treated 24h31.184512
GSM687697Patient 441 treated 24h34.494513
GSM687709Patient 448 treated 24h11.88095
GSM687725Patient 451 treated 24h44.445518
GSM687729Patient 452 treated 24h150.53935
GSM687727Patient 451 treated 4 weeks42.225518
GSM687731Patient 452 treated 4 weeks15.75858